New report sets out clear steps pharma cos to curb AMR risk in antibiotic production
The report also demonstrates how proactively adopting and scaling responsible manufacturing practices is a critical way for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Fresenius Kabi
Claris settles patent case with Fresenius Kabi over Diprivan generic
In December 2014, Fresenius Kabi had filed a suit against Claris Lifesciences to block commercialisation of its ANDA for Propofol